Positive progress and achievement from AMWG

The Minister for Health, Sussan Ley, has announced the publication of new guidance for post market reviews of medicines listed on the Pharmaceutical Benefits Scheme (PBS).

Page last updated: 18 March 2015

PDF printable version of Positive progress and achievement from AMWG (PDF 314 KB)

18 March 2015

The Minister for Health, Sussan Ley, has today announced the publication of new guidance for post market reviews of medicines listed on the Pharmaceutical Benefits Scheme (PBS).

The new guidance has been agreed between the pharmaceutical industry, Medicines Australia and the Australian Government.

Ms Ley congratulated the Access to Medicines Working Group (AMWG) for producing a significantly improved version of the PBS Post-Market Review Framework, giving industry and other stakeholders more clarity and certainty around processes, and timelines and opportunity for input.

The initiative is seen as the first milestone achieved by the AMWG, since its revamp by the Government as a forum for discussion of PBS policies with the pharmaceutical industry.

A post-market review is a formal approach to monitoring medicines listed on the PBS. It aims to improve quality use of medicines, education for patients and prescribers, and ensure the cost-effectiveness and ongoing viability of the PBS.

“Post-market reviews are important,” Ms Ley said. “By looking at how medicines are being used once they are listed on the PBS, we can ensure the quality use of medicines and the ongoing sustainability of the PBS.”

Ms Ley noted the successful outcomes that can be achieved when Government and industry work together to solve a joint area of concern.

“The project team, consisting of representatives from the pharmaceutical industry, Medicines Australia and my Department worked collaboratively with the generic medicines sector to resolve issues of concern for members of the industry,” Ms Ley said.

“The framework has been the subject of discussions between government and industry for a number of years, with industry particularly concerned about the lack of clarity around processes and timeframes.

“It is pleasing to see the reinvigorated AMWG was able to resolve this issue in such a timely manner, and that it will provide the necessary clarity and certainty for industry and other stakeholders.”

The new framework will be published on the PBS website. The work is in line with the Government’s objective to improve PBS processes to ensure Australians have access to safe, clinically effective and cost-effective medicines, while also safeguarding the sustainability of the PBS.

Recent or current post-market reviews include medicines used to treat children with asthma, Authority Required PBS Listings and the Life Savings Drugs Programme.

Minister Ley said she looked forward to making further announcements about the AMWG’s work on other PBS policies, which was progressing well.

Further details are accessible through the PBS website.

ENDS

Minister Ley’s Media Contact: James Murphy – 0478 333 974

View by date:

Top of Page